ZDA
ALXN
Zweig-DiMenna Associates’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q1 | – | Sell |
-110,260
| Closed | -$21M | – | 289 |
|
2015
Q4 | $21M | Sell |
110,260
-104,686
| -49% | -$20M | 1.05% | 31 |
|
2015
Q3 | $33.6M | Buy |
+214,946
| New | +$33.6M | 1.46% | 13 |
|
2015
Q2 | – | Sell |
-106,823
| Closed | -$18.5M | – | 324 |
|
2015
Q1 | $18.5M | Sell |
106,823
-11,864
| -10% | -$2.06M | 0.78% | 43 |
|
2014
Q4 | $22M | Sell |
118,687
-57,504
| -33% | -$10.6M | 0.94% | 32 |
|
2014
Q3 | $29.2M | Buy |
176,191
+46,091
| +35% | +$7.64M | 1.28% | 14 |
|
2014
Q2 | $20.3M | Buy |
+130,100
| New | +$20.3M | 0.93% | 35 |
|
2013
Q3 | – | Sell |
-38,750
| Closed | -$3.57M | – | 272 |
|
2013
Q2 | $3.57M | Buy |
+38,750
| New | +$3.57M | 0.14% | 129 |
|